Rosemont Pharmaceuticals News and Activities

View the org chart displaying its 29 main executives

Most searched biographies at Rosemont Pharmaceuticals

• Alok Sonig, Chief Executive Officer
• Olivia Craig, Non Executive Director
• Deepak Murpani, Chief Scientific Officer

Popular executive movements at Rosemont Pharmaceuticals

• John Denman, Vice President, United States, has left the company  (posted on June 8 2026).
• Ed Cahill, Chief Scientific Officer, has left the company  (posted on June 8 2026).
• Jacqueline Bonam, Quality Director, has left the company  (posted on June 8 2026).

Click here to view some more movements at Rosemont Pharmaceuticals

Create your alert
to follow the executive moves at Rosemont Pharmaceuticals.

Rosemont Pharmaceuticals has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Rosemont Pharmaceuticals

• Rosemont | News

Social media about Rosemont Pharmaceuticals

• Rosemont Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Rosemont Pharmaceuticals on LinkedIn, X (Twitter) & YouTube